Advanced Solutions Life Sciences (ASLS) is at the forefront of regenerative medicine and tissue engineering, specializing in the development and commercialization of integrated 3D bioprinting solutions. Their flagship BioAssemblyBot® platform, alongside advanced bioinks and proprietary software like TSIMPLE BioInk™, empowers researchers and clinicians to design, create, and validate functional human tissues and organoids. ASLS is committed to advancing scientific discovery and therapeutic applications by providing tools that enable the precise and automated fabrication of complex biological structures, aiming to revolutionize drug discovery, personalized medicine, and tissue replacement therapies.
The Louisville headquarters serves as the primary center for Advanced Solutions Life Sciences' research and development, manufacturing of its BioAssemblyBot® systems and bioinks, corporate administration, software development, and global customer support.
The facility is equipped with state-of-the-art laboratories for biofabrication research, development, and testing, including environments for bioink formulation and 3D bioprinter assembly and demonstration. It supports both scientific innovation and product engineering.
The work culture at ASLS headquarters is characterized by innovation, collaboration, and a strong scientific focus. It brings together multidisciplinary teams of engineers, biologists, software developers, and commercial staff dedicated to pioneering advancements in regenerative medicine and bioprinting.
ASLS's Louisville headquarters is pivotal as the innovation hub where its core technologies, including the BioAssemblyBot® platform, are conceived, developed, and manufactured. It plays a crucial role in the Kentucky life sciences ecosystem and contributes to global advancements in tissue engineering.
While Advanced Solutions Life Sciences is headquartered in Louisville, Kentucky, USA, its technologies and expertise have a global reach. The company supports researchers, pharmaceutical companies, and academic institutions across North America, Europe, and Asia through the sale and support of its BioAssemblyBot® systems, bioinks, and software. ASLS actively participates in international conferences and collaborations, fostering a worldwide network to advance the field of biofabrication and regenerative medicine.
1201 Herr Lane, Suite 150
Louisville
KY
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Advanced Solutions Life Sciences' leadership includes:
Advanced Solutions Life Sciences has been backed by several prominent investors over the years, including:
No significant public announcements regarding executive hires or departures specifically for Advanced Solutions Life Sciences have been identified in the past 12 months, suggesting leadership stability within its dedicated life sciences team.
Discover the tools Advanced Solutions Life Sciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Advanced Solutions Life Sciences likely uses standard professional email formats based on their domain 'advlifesciences.com'. Common patterns include combining the first initial and last name, or first name and last name separated by a dot.
[first_initial][last]@advlifesciences.com
Format
jdoe@advlifesciences.com
Example
80%
Success rate
Advanced Solutions Life Sciences News • October 17, 2023
Advanced Solutions Life Sciences (ASLS) announced its participation and presentation of new data on its BioAssemblyBot® platform and biofabrication workflows at the World Biofabrication & Bioprinting Conference (WBF) 2023 in Saskatoon, SK, Canada. The company highlighted innovations in automating tissue and organoid engineering, contributing to the global dialogue on the future of biofabrication....more
Advanced Solutions Life Sciences News • January 25, 2023
Advanced Solutions Life Sciences has introduced TSIMPLE BioInk™, a novel ready-to-use, room-temperature stable bioink designed to simplify 3D bioprinting workflows and enhance reproducibility for researchers. This new product aims to make advanced bioprinting more accessible and consistent for creating tissue models and constructs....more
Advanced Solutions Life Sciences News • May 2, 2022
Advanced Solutions Life Sciences (ASLS) announced it would feature its BioAssemblyBot® 400 (BAB 400) platform at the Tissue Engineering and Regenerative Medicine International Society – Americas (TERMIS-AM) conference. The showcase aimed to demonstrate the capabilities of the BAB 400 in advancing research in tissue engineering and regenerative medicine through automated and precise biofabrication....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Advanced Solutions Life Sciences, are just a search away.